Biotech Values

[DewDiligence]

FCSC longs have a curious tendency to post factually erroneous statements. For instance, one recent post says: “If the FDA clears laViv at the end of June, Fibrocell will be entering and expanding the $1 billion annual market in injectable aesthetics.”

According to IMS, the entire worldwide market for dermal fillers in all indications does not amount to as much as $1B.